Zacks Investment Research downgraded shares of ENVISION HLTHCR (EVHC) from OUTPERFORM to NEUTRAL on February 18, 2014, with a target price of $38.60.
Envision Healthcare Holdings, Inc. engages in providing physician-led, outsourced medical services primarily in the United States. The Company, through its subsidiaries, provides medical services and solutions, including emergency, anesthesiology, hospitalist/inpatient care, radiology, tele-radiology and surgery. It offers an array of healthcare-related services to consumers, hospitals, healthcare systems, health plans and local, state and national government entities. Envision Healthcare Holdings, Inc. is headquartered in Greenwood Village, Colorado.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on ENVISION HLTHCR (EVHC),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment